Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer research: New US patent to Swedish researchers

29.01.2014
Alf Månsson and Sven Tågerud, professors at Linnaeus University in Sweden, have been granted a patent in the US for their research on nanodiagnostics. Their ideas will, among other things, improve diagnosing for prostate cancer.

The ideas that have been patented deal with improved ways of detecting illness signals in blood samples. Through their research they have come up with a way of detecting very low levels of illness-related substances, such as, for instance, prostate-specific antigen, something that is important when a follow-up is carried out after surgery. Another possibility that comes with the idea is the ability to detect multiple markers simultaneously.

As a result, diagnostics for, for instance, prostate cancer can be improved.
The patent has been given the name “Detection conjugate” and will be printed and published in the US sometime during the first months of 2014. The patent adds to an earlier Swedish patent.

- This is a major step towards the commercialisation of our ideas concerning diagnostics and, generally speaking, an important recognition”, says Alf Månsson.

“In addition, since we handed in our Swedish patent application, we have published a number of scientific articles which have shown that our ideas can be put into practice, for instance in J Nanobiotechnology and Nano Letters.

For further information, please contact
Alf Månsson, professor of physiology, phone: +4670-886 62 43
Sven Tågerud, professor of pharmacology, phone: +46480-446 256
Christina Dahlgren, senior press officer, phone: +4670-572 26 56
Weitere Informationen:
http://www.jnanobiotechnology.com/content/11/1/14 Article in J Nanobiotechnology
http://pubs.acs.org/doi/full/10.1021/nl404032k Article in Nano Letters

Christina Dahlgren | idw
Further information:
http://www.vr.se

More articles from Health and Medicine:

nachricht Discovery points to a new path toward a universal flu vaccine
03.07.2015 | Rockefeller University

nachricht "CCS Telehealth Ostsachsen", Germany's largest telemedicine project, goes online in Dresden
02.07.2015 | Universitätsklinikum Carl Gustav Carus Dresden

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens receives order for offshore wind power plant in Great Britain

03.07.2015 | Press release

'Déjà vu all over again:' Research shows 'mulch fungus' causes turfgrass disease

03.07.2015 | Agricultural and Forestry Science

Discovery points to a new path toward a universal flu vaccine

03.07.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>